Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon

被引:26
作者
Mule, Flavia [1 ]
Amato, Antonella [1 ]
Baldassano, Sara [1 ]
Serio, Rosa [1 ]
机构
[1] Univ Palermo, Lab Fisiol Gen, Dipartimento Biol Cellulare & Sviluppo, I-90128 Palermo, Italy
关键词
cannabinoids; CB1; receptors; intestinal motility; NANC contraction; NANC relaxation;
D O I
10.1016/j.phrs.2007.04.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is well accepted that endogenous cannabinoids and CB I receptors are involved in the regulation of smooth muscle contractility and intestinal motility, through a mechanism mainly related to reduction of acetylcholine release from cholinergic nerve endings. Because, few data exist on a possible modulatory action of the cannabinoid agents on the non-adrenergic non-cholinergic (NANC) excitatory and inhibitory neurotransmission, the aim of the present study was to investigate the effects of cannabinoid drugs on the NANC responses elicited by electrical field stimulation (EFS) in the circular muscle of mouse proximal colon. Colonic contractions were monitored as changes in endoluminal pressure. In NANC conditions, EFS evoked TTX-sensitive responses, characterized by a relaxation, nitrergic in origin, followed by a contraction. The EFS-evoked contraction was significantly reduced by SR48968, NK2 receptor antagonist, and abolished by co-administration of SR48968 and SR140333, NK1 receptor antagonist, suggesting that it was due to release of tachykinins. The cannabinoid receptor synthetic agonist, WIN55,212- 2, the putative endogenous ligand, anandamide, the selective CB I receptor agonist ACEA, but not the selective CB2 receptor agonist JWH-015, produced a concentration-dependent reduction of the NANC contractile responses, without affecting the NANC relaxation. ACEA or anandamide did not modify the contractions induced by exogenous [beta-Ala(8)]-NKA(4-10), agonist of NK2 receptors. The selective antagonist of CB1 receptors, SR141716A, per se failed to affect the EFS-evoked responses, but antagonized the inhibitory effects of WIN55,212-2, anandamide and ACEA on NANC contractile responses. AM630, CB2 receptor antagonist, did not modify the inhibitory effects of WIN55,212-2 or anandamide. URB597, inhibitor of the fatty acid amide hydrolase, enzyme which catalyze the hydrolysis of anandamide, was without any effect on the NANC evoked responses. We conclude that the activation of prejunctional CB I receptors produces inhibition of NANC contractile responses in mouse colonic preparations. However, endogenous ligands do not seem to modulate tonically the NANC transmission in mouse colon. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 41 条
[1]   Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach [J].
Adami, M ;
Frati, P ;
Bertini, S ;
Kulkarni-Narla, A ;
Brown, DR ;
de Caro, G ;
Coruzzi, G ;
Soldani, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) :1598-1606
[2]   Modulation of the release of endogenous adenosine by cannabinoids in the myenteric preparation of the guinea-pig plexus-longitudinal muscle ileum [J].
Begg, M ;
Dale, N ;
Llaudet, E ;
Molleman, A ;
Parsons, ME .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (08) :1298-1304
[3]  
Calignano A, 1997, EUR J PHARMACOL, V340, pR7
[4]   Fatty acid amide hydrolase controls mouse intestinal motility in vivo [J].
Capasso, R ;
Matias, I ;
Lutz, B ;
Borrelli, F ;
Capasso, F ;
Marsicano, G ;
Mascolo, N ;
Petrosino, S ;
Monory, K ;
Valenti, M ;
Di Marzo, V ;
Izzo, AA .
GASTROENTEROLOGY, 2005, 129 (03) :941-951
[5]   Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract [J].
Casu, MA ;
Porcella, A ;
Ruiu, S ;
Saba, P ;
Marchese, G ;
Carai, MAM ;
Reali, R ;
Gessa, GL ;
Pani, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (01) :97-105
[6]   The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues [J].
Clapper, Jason R. ;
Duranti, Andrea ;
Tontini, Andrea ;
Mor, Marco ;
Tarzia, Giorgio ;
Piomelli, Daniele .
PHARMACOLOGICAL RESEARCH, 2006, 54 (05) :341-344
[7]   Cannabinoid modulation of intestinal propulsion in mice [J].
Colombo, G ;
Agabio, R ;
Lobina, C ;
Reali, R ;
Gessa, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 344 (01) :67-69
[8]   The gastrointestinal pharmacology of cannabinoids: an update [J].
Coutts, AA ;
Izzo, AA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (06) :572-579
[9]   Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus [J].
Coutts, AA ;
Irving, AJ ;
Mackie, K ;
Pertwee, RG ;
Anavi-Goffer, S .
JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 448 (04) :410-422
[10]   Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus [J].
Coutts, AA ;
Pertwee, RG .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1557-1566